RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 129 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $33,702,823 | -27.5% | 4,371,313 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $46,510,770 | +34.3% | 4,371,313 | +2.7% | 0.01% | +33.3% |
| Q2 2022 | $34,638,199 | +246.2% | 4,255,307 | +204.5% | 0.01% | +350.0% |
| Q1 2022 | $10,004,489 | -58.2% | 1,397,275 | +0.0% | 0.00% | -60.0% |
| Q4 2021 | $23,935,000 | +108.0% | 1,397,274 | +179.5% | 0.01% | +66.7% |
| Q3 2021 | $11,505,000 | -37.0% | 500,000 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $18,250,000 | – | 500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CRV, LLC | 733,986 | $26,790,000 | 44.35% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 1,388,889 | $50,694,446,000 | 9.21% |
| Samsara BioCapital, LLC | 775,583 | $28,309,000 | 3.50% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $55,088,000 | 3.17% |
| Laurion Capital Management LP | 3,858,617 | $140,839,000 | 0.78% |
| Casdin Capital, LLC | 548,156 | $20,008,000 | 0.51% |
| ALLEN OPERATIONS LLC | 68,104 | $2,486,000 | 0.43% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 472,552 | $17,248,000 | 0.40% |
| Ratan Capital Management LP | 110,000 | $4,015,000 | 0.35% |
| Comprehensive Financial Management LLC | 1,109,395 | $40,493,000 | 0.34% |